Analysts expect Selecta Biosciences, Inc. (NASDAQ:SELB) to post sales of $5.83 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Selecta Biosciences’ earnings, with the lowest sales estimate coming in at $5.65 million and the highest estimate coming in at $6.00 million. Selecta Biosciences reported sales of $6.65 […]